How is the Alto Neuroscience Inc. today?

The Alto Neuroscience Inc. today is trading in the down by -4.94% at 2.50.

What is Alto Neuroscience Inc. Annual Net Profit?

Alto Neuroscience Inc. Annual Net Profit fell 69.21% in the last year to $61.43 M. Its sector's average net profit growth for the last fiscal year was -14.79%.

What is Alto Neuroscience Inc. Price to Earning Ratio?

Alto Neuroscience Inc. Price to Earning Ratio is -1.07, which is negative.

What is Alto Neuroscience Inc. Stock Price?

Alto Neuroscience Inc. Stock Price fell 77.27% and underperformed its sector by 78.76% in the past year.

What is Alto Neuroscience Inc. Quarterly Net profit?

Alto Neuroscience Inc. Quarterly Net profit fell 13.06% YoY to $15.17 M. Its sector's average net profit growth YoY for the quarter was -19.22%.

What is Alto Neuroscience Inc. Debt to Equity Ratio?

Alto Neuroscience Inc. Debt to Equity Ratio of 0.11 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Alto Neuroscience Inc. Return on Equity(ROE)?

Alto Neuroscience Inc. Return on Equity(ROE) for the last financial year was -153.99%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Alto Neuroscience Inc. Mutual Fund Holding?

Alto Neuroscience Inc. Mutual Fund Holding decreased by 0.19% in the last quarter to 27.

What is Alto Neuroscience Inc. Interest Coverage Ratio?

Alto Neuroscience Inc. Interest Coverage Ratio is -43.68, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Alto Neuroscience Inc. Institutional Holding?

Alto Neuroscience Inc. Institutional Holding decreased by 3.28% in the last quarter to 78.56.

Alto Neuroscience Inc. XNYS: ANRO

Alto Neuroscience Inc. Live Share Price Today, Share Analysis and Chart

Name: Alto Neuroscience Inc.: Is Infosys Ltd. worth buying?
Item: Alto Neuroscience Inc.
Rating: 1.12708325
Author: Trendlyne DVM scores

about

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different cli...

2.50 -0.13 (-4.94%)

85.75% Fall from 52W High

65,522 XNYS Volume

XNYS 04 Jun, 2025 11:25 AM (EDT)

Not Eligible

-

Expensive Valuation

14.8 / 100

Technically Bearish

30.3 / 100

No estimates available

Alto Neuroscience Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Alto Neuroscience Inc. FAQ

How is Alto Neuroscience Inc. today?

Alto Neuroscience Inc. today is trading in the red, and is down by -4.94% at 2.50.

How has Alto Neuroscience Inc. performed historically?

Alto Neuroscience Inc. is currently trading down -4.94% on an intraday basis. In the past week the stock fell -12.89%. stock has been down -20.38% in the past quarter and fell -77.27% in the past year. You can view this in the overview section.